Impact of clinical decision support on paediatric emergency care. : Impact of clinical decision support on pediatric emergency care.
Medienart: |
Klinische Studie |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
WHO International Clinical Trials Registry Platform - (2023) vom: 03. Apr. Zur Gesamtaufnahme - year:2023 |
---|
Sprache: |
Englisch |
---|
Links: |
Volltext [kostenfrei] |
---|
Anmerkungen: |
WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 2010-04-28, Last updated: 2023-04-06 |
---|
ICTRP ID: |
NTR2304 |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
WHO004424093 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | WHO004424093 | ||
003 | DE-627 | ||
005 | 20230425164734.0 | ||
007 | cr uuu---uuuuu | ||
008 | 210507s2023 xx |||||o 00| ||eng c | ||
035 | |a (DE-627)WHO004424093 | ||
035 | |a (UBBS_Klinische_Studien_WHO)NTR2304 | ||
035 | |a (UBBS_Klinische_Studien_WHO)NL2180 | ||
035 | |a (UBBS_Klinische_Studien_WHO)ZonMW / METC-MEC : 17099.2503 / mec-2008-071 | ||
035 | |a (UBBS_Klinische_Studien_WHO)ISRCTN wordt niet meer aangevraagd. | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
245 | 1 | 0 | |a Impact of clinical decision support on paediatric emergency care. |b Impact of clinical decision support on pediatric emergency care. |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 2010-04-28, Last updated: 2023-04-06 | ||
650 | 4 | |a Medical Condition: Children with vomiting/ diarrhea constitute about 15% of the pediatric emergency admissions1. Children under the age of five are most infected with viral pathogens as Rota and Noro. The clinical manifestations of viral gastroenteritis include diarrhea, vomiting, fever, anorexia, headache, abdominal cramps and myalgia. The constellation of symptoms varies from day to day and from person to person. Illness usually begins 12 hours to four days after exposure and generally lasts for three to seven days. Usually these diseases are self limiting, but these children are at risk for dehydration. In current practice, these patients are triaged by the nurse then evaluated by the physician for hydration status and diagnosis and, if necessary, fluid replacement therapy is started. Although oral rehydration therapy is the preferred treatment for mild to moderate dehydration, it remains underused. A consensus based guideline2 with assessment for hydration status and recommendations on oral rehydration by experienced emergency care nurses reduced in a before-after trial the number of intravenous rehydrations, unscheduled readmissions and total time spent in hospital3.1 Bouwhuis et al. Ned Tijdschr Geneeskd. 2001;145:1847-51.2 Armon et al. Arch Dis Child. 2001;85:132-42.3 Boyd et al. Emerg Med J. 2005;22:116-7. | |
650 | 4 | |a Study Type: Interventional | |
650 | 4 | |a Recruitment Status: Completed | |
650 | 4 | |a 610 | |
773 | 0 | 8 | |i Enthalten in |t WHO International Clinical Trials Registry Platform |g (2023) vom: 03. Apr. |
773 | 1 | 8 | |g year:2023 |g day:03 |g month:04 |
856 | 4 | 0 | |u https://www.onderzoekmetmensen.nl/en/trial/22275 |z kostenfrei |3 Volltext |
912 | |a GBV_CTG | ||
912 | |a SSG-OLC-PHA | ||
951 | |a AR | ||
952 | |j 2023 |b 03 |c 04 |